Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression

International Journal of Medical Sciences

Volumn 11, Issue 1, 2013, Pages 17-23

  Ye, Panpan ^a,b   Liu, Jian ^a,b   He, Fengying ^a,b   Xu, Wen ^a,b   Yao, Ke ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Zhejiang Provincial Key Lab of Ophthalmology   (China)

Author keywords

Diabetic retinopathy; Hypoxia; Matrix metalloproteinase 9; MicroRNA 126; Vascular endothelial growth factor

Indexed keywords

GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA 126; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOWN REGULATION; FLOW CYTOMETRY; HYPOXIA; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; UPREGULATION;

DIABETIC RETINOPATHY.; HYPOXIA; MATRIX METALLOPROTEINASE-9; MICRORNA-126; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANIMALS; CELL CYCLE; CELL HYPOXIA; CELL LINE; CHOROID; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; MALE; MATRIX METALLOPROTEINASE 9; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, WISTAR; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890498926     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.7329     Document Type: Article

References (23)

1. Nyengaard JR, Ido Y, Kilo C, Williamson JR. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes. 2004; 53: 2931-8. doi:53/11/2931 [pii].
2. Grammas P, Riden M. Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells. Microvasc Res. 2003; 65: 18-23. doi:S002628620200016X [pii].
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992; 267: 10931-4.
4. Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ. Biological functions of microRNAs: a review. J Physiol Biochem. 2011; 67: 129-39. doi:10.1007/s13105-010-0050-6.
5. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011; 39: D152-7. doi:gkq1027 [pii]10.1093/nar/gkq1027.
6. Caporali A, Emanueli C. MicroRNA regulation in angiogenesis. Vascul Pharmacol. 2011; 55: 79-86. doi:S1537-1891(11)00070-X [pii]10.1016/j.vph.2011.06.006.
7. Kuehbacher A, Urbich C, Dimmeler S. Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci. 2008; 29: 12-5. doi:S0165-6147(07)00277-5 [pii]10.1016/j.tips.2007.10.014.
8. Fitch MJ, Campagnolo L, Kuhnert F, Stuhlmann H. Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev Dyn. 2004; 230: 316-24. doi:10.1002/dvdy.20063.
9. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008; 15: 261-71. doi:S1534-5807(08)00281-5 [pii]10.1016/j.devcel.2008.07.002.
10. Liu B, Peng XC, Zheng XL, Wang J, Qin YW. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer. 2009; 66: 169-75. doi:S0169-5002(09)00012-9 [pii]10.1016/j.lungcan.2009.01.010.
11. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol. 2012; 53: 64-72. doi:10.1016/j.yjmcc.2012.04.003 S0022-2828(12)00150-2 [pii].
12. Frank RN. Diabetic retinopathy. N Engl J Med. 2004; 350: 48-58. doi:10.1056/NEJMra021678 350/1/48 [pii].
13. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol. 1995; 113: 1538-44.
14. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol. 1996; 114: 66-71.
15. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes. 1999; 48: 1899-906.
16. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008; 15: 272-84. doi:S1534-5807(08)00287-6 [pii]10.1016/j.devcel.2008.07.008.
17. Hartmann D, Thum T. MicroRNAs and vascular (dys)function. Vascul Pharmacol. 2011; 55: 92-105. doi:S1537-1891(11)00072-3 [pii]10.1016/j.vph.2011.07.005.
18. Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen CZ, et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development. 2008; 135: 3989-93. doi:dev.029736 [pii]10.1242/dev.029736.
19. Bai Y, Bai X, Wang Z, Zhang X, Ruan C, Miao J. MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors. Exp Mol Pathol. 2011; 91: 471-7. doi:S0014-4800(11)00056-6 [pii]10.1016/j.yexmp.2011.04.016.
20. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010; 107: 677-84. doi:CIRCRESAHA.109.215566 [pii]10.1161/CIRCRESAHA.109.215566.
21. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010; 107: 810-7. doi:CIRCRESAHA.110.226357 [pii]10.1161/CIRCRESAHA.110.226357.
22. Xu J, Zhu D, Sonoda S, He S, Spee C, Ryan SJ, et al. Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9. Angiogenesis. 2012; 15: 213-27. doi:10.1007/s10456-012-9254-4.
23. Nguyen M, Arkell J, Jackson CJ. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol. 2001; 33: 960-70. doi:S1357-2725(01)00007-3 [pii].